02917nas a2200313   4500008004100000022001400041245010400055210006900159260000800228300001100236490000800247520193700255653002102192653002602213653001402239653001202253653001102265653001702276653002402293100002102317700001802338700001502356700001902371700002002390700002302410700001702433700002602450856012702476       2025                        eng d  a0141-813000aEngineered silk matrix as a substitute for acellular dermal matrix in breast reconstruction surgery0 aEngineered silk matrix as a substitute for acellular dermal matr  cJUN  a1440170 v3123 a<p>
	Implant-based breast reconstruction is a common standard of care for breast cancer patients following mastectomy. To support implant weight and placement, surgeons utilize autologous tissues, acellular dermal matrices (ADMs), or synthetic meshes. While ADMs provide structural support, they present significant risks, including infection transmission and seroma. Conversely, synthetic meshes exhibit poor cellular adhesion, leading to inadequate tissue integration. To address these challenges, there is a need for a matrix that enhances tissue integration while minimizing infection risks and other complications. Silk fibroin (SF), a natural biopolymer, possesses excellent biocompatibility and mechanical properties. This study introduces a novel engineered silk matrix (ESM) as an advanced solution for soft tissue regeneration, specifically in breast reconstruction surgery. The present study establishes the safety of ESM and evaluates its potential a tissue regeneration matrix through extensive in-vitro and in-vivo analyses. In-vitro assays demonstrated superior cellular adhesion, proliferation of human mammary fibroblast cells (HMFCs), collagen deposition and angiogenesis in ESM compared to collagen matrices and ADMs. Safety assessments, conducted in accordance with ISO 10993 guidelines, confirmed noncytotoxic nature of ESM. Furthermore, subcutaneous implantation revealed no systemic toxicity or adverse tissue reactions. In-vivo studies utilizing a Yorkshire pig model of simulated breast reconstruction surgery, demonstrated superior performance of ESM over collagen matrices in tissue regeneration. The findings showed enhanced fibroblast density, increased collagen deposition, and improved vascularization. These results suggest that ESM is a safer and more effective alternative to ADMs in breast reconstruction, with the potential to revolutionize post-mastectomy care for breast cancer patients.</p>
10aBiocompatibility10aBreast reconstruction10aISO 1099310aPolymer10aSafety10aSilk protein10atissue regeneration1 aDeshpande, Rucha1 aShukla, Swati1 aKale, Amod1 aSayyad, Raeesa1 aKewale, Bhawana1 aDeshmukh, Narendra1 aNisal, Anuya1 aVenugopalan, Premnath  uhttps://library.ncl.res.in/content/engineered-silk-matrix-substitute-acellular-dermal-matrix-breast-reconstruction-surgery02126nas a2200265   4500008004100000022001400041245009700055210006900152260000800221300001100229490000700240520127600247653002101523653001501544653001401559653001701573653001801590100002101608700002401629700001901653700001801672700001701690700002601707856012701733       2025                        eng d  a1616-518700aEngineered silk-dressing for acceleratedwound healing: biocompatibility and efficacy studies0 aEngineered silkdressing for acceleratedwound healing biocompatib  cNOV  ae003230 v253 a<p>
	Advanced wound care dressings are essential for improving clinical outcomes. The present study investigates the wound management potential of a unique dressing fabricated from silk proteins. The dressing was characterized for its physical and structural properties, including surface texture, porosity, fluid absorption capacity, and moisture vapor transmission rate. These parameters have been found to be critical for optimal wound healing. In vivo full thickness wound healing studies in a rat model validated the efficacy of the Silk-dressing compared to conventional cotton gauze and commercial polyurethane foam dressings. Histopathological analysis confirmed improved re-epithelialization, collagen deposition, angiogenesis, and formation of secondary follicles. Key advantages of Silk-dressing included non-adherence, absorption of exudate, maintenance of optimal moisture at wound site and acceleratedwound closure. Biocompatibility studies were also conducted in accordance with ISO 10993 guidelines, demonstrating no cytotoxicity, irritation, sensitization, or pyrogenicity. These findings highlight the potential of this uniquely designed Silk-dressing as a superior alternative for wound management, with a potential to improve clinical outcomes.</p>
10aBiocompatibility10abiopolymer10aISO 1099310aSilk protein10awound Healing1 aDeshpande, Rucha1 aPillai, Lakshmi, R.1 aSayyad, Raeesa1 aShukla, Swati1 aNisal, Anuya1 aVenugopalan, Premnath  uhttps://library.ncl.res.in/content/engineered-silk-dressing-acceleratedwound-healing-biocompatibility-and-efficacy-studies